SLC22A12 and renal cell adenocarcinoma: SLC22A12 mRNA and protein expression levels in RCC cell lines (786-O, ACHN, A-498, OSRC-2, and Caki-1) were decreased compared to the normal cell line HK-2 (Figures 5D, E).